Gnosis by Lesaffre launches fermentation derived salidroside as alternative to Rhodiola extracts

Photo © AdobeStock.com/dizain

Gnosis by Lesaffre has announced the launch of a natural energy solution called Landkind Pure Salidroside. Salidroside is the most studied bioactive in Rhodiola rosea or Rhodiola crenulate, with over 680 scientific papers on Pubmed, explains the company in a press release. The company’s Pure Salidroside is isolated using its proprietary fermentation process.

“Crafted by fermentation, we only produce the best bioactive of the botanical in a pure form without the possible trace amounts of heavy metals, pesticides, and residual solvents that may be found in natural plant extracts,” explained José Luis Pinedo Rivera, the company’s product manager, new molecules, in a press release. “Our Landkind Pure Salidroside is a bioengineered compound, whose safety is ensured by toxicological studies, with supporting clinical data.”

The company’s fermentation process bypasses the need to harvest Rhodiola rosea, which has been added to the CITES (Convention on International Trade in Endangered Species of Wild Fauna and Flora) list of endangered species. The Pure Salidroside also only requires 60 mg/day suggested dosage.

“Our Landkind Pure Salidroside requires a lower dose versus Rhodiola extracts, which is much more convenient for formulators, leaving space in the product for other bioactives,” said Damien Zanalda, Gnosis by Lesaffre’s global sales director, in a press release. “Our partners can use our targeted bioactive to provide a natural energy component to their existing products or use it as a base for their natural energy innovation.”